Milk Exosome-Liposome Hybrid Vesicles with Self-Adapting Surface Properties Overcome the Sequential Absorption Barriers for Oral Delivery of Peptides
- PMID: 39099105
- DOI: 10.1021/acsnano.4c02560
Milk Exosome-Liposome Hybrid Vesicles with Self-Adapting Surface Properties Overcome the Sequential Absorption Barriers for Oral Delivery of Peptides
Abstract
Milk exosomes (mExos) have demonstrated significant promise as vehicles for the oral administration of protein and peptide drugs owing to their superior capacity to traverse epithelial barriers. Nevertheless, certain challenges persist due to their intrinsic characteristics, including suboptimal drug loading efficiency, inadequate mucus penetration capability, and susceptibility to membrane protein loss. Herein, a hybrid vesicle with self-adaptive surface properties (mExos@DSPE-Hyd-PMPC) was designed by fusing functionalized liposomes with natural mExos, aiming to overcome the limitations associated with mExos and unlock their full potential in oral peptide delivery. The surface property transformation of mExos@DSPE-Hyd-PMPC was achieved by introducing a pH-sensitive hydrazone bond between the highly hydrophilic zwitterionic polymer and the phospholipids, utilizing the pH microenvironment on the jejunum surface. In comparison to natural mExos, hybrid vesicles exhibited a 2.4-fold enhancement in the encapsulation efficiency of the semaglutide (SET). The hydrophilic and neutrally charged surfaces of mExos@DSPE-Hyd-PMPC in the jejunal lumen exhibited improved preservation of membrane proteins and efficient traversal of the mucus barrier. Upon reaching the surface of jejunal epithelial cells, the highly retained membrane proteins and positively charged surfaces of the hybrid vesicle efficiently overcame the apical barrier, the intracellular transport barrier, and the basolateral exocytosis barrier. The self-adaptive surface properties of the hybrid vesicle resulted in an oral bioavailability of 8.7% and notably enhanced the pharmacological therapeutic effects. This study successfully addresses some limitations of natural mExos and holds promise for overcoming the sequential absorption barriers associated with the oral delivery of peptides.
Keywords: hybrid vesicles; milk exosomes; oral peptides; sequential absorption barriers; surface properties.
Similar articles
-
Modulating the elasticity of milk exosome-based hybrid vesicles to optimize transepithelial transport and enhance oral peptide delivery.J Control Release. 2025 Apr 10;380:36-51. doi: 10.1016/j.jconrel.2025.01.090. Epub 2025 Feb 4. J Control Release. 2025. PMID: 39892650
-
Milk Exosome-Based Delivery System for Probiotic Encapsulation That Enhances the Gastrointestinal Resistance and Adhesion of Probiotics.Nutrients. 2025 Mar 6;17(5):923. doi: 10.3390/nu17050923. Nutrients. 2025. PMID: 40077793 Free PMC article.
-
An exosomal approach for oral delivery of resveratrol: Implications for inflammatory bowel disease treatment in rat model.Life Sci. 2024 Jun 1;346:122638. doi: 10.1016/j.lfs.2024.122638. Epub 2024 Apr 12. Life Sci. 2024. PMID: 38614294
-
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.Adv Drug Deliv Rev. 2022 Mar;182:114097. doi: 10.1016/j.addr.2021.114097. Epub 2022 Jan 7. Adv Drug Deliv Rev. 2022. PMID: 34999121 Review.
-
Molecular Design of Layer-by-Layer Functionalized Liposomes for Oral Drug Delivery.ACS Appl Mater Interfaces. 2020 Sep 30;12(39):43341-43351. doi: 10.1021/acsami.0c13504. Epub 2020 Sep 21. ACS Appl Mater Interfaces. 2020. PMID: 32877163 Review.
Cited by
-
Leveraging nature's nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications.Sci Adv. 2025 Feb 28;11(9):eads5249. doi: 10.1126/sciadv.ads5249. Epub 2025 Feb 26. Sci Adv. 2025. PMID: 40009680 Free PMC article. Review.
-
A state-of-the-art review of the recent advances of theranostic liposome hybrid nanoparticles in cancer treatment and diagnosis.Cancer Cell Int. 2025 Jan 27;25(1):26. doi: 10.1186/s12935-024-03610-z. Cancer Cell Int. 2025. PMID: 39871316 Free PMC article. Review.
-
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases.Pharmaceutics. 2025 Feb 12;17(2):238. doi: 10.3390/pharmaceutics17020238. Pharmaceutics. 2025. PMID: 40006605 Free PMC article. Review.
-
Drug delivery strategies with lipid-based nanoparticles for Alzheimer's disease treatment.J Nanobiotechnology. 2025 Feb 10;23(1):99. doi: 10.1186/s12951-025-03109-3. J Nanobiotechnology. 2025. PMID: 39930497 Free PMC article. Review.
-
Therapeutic application of extracellular vesicles in human diseases.Mol Ther. 2025 May 7;33(5):2243-2251. doi: 10.1016/j.ymthe.2025.04.002. Epub 2025 Apr 3. Mol Ther. 2025. PMID: 40186351 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources